611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
Is Rise in Liver Damage Tied to More Drinking During Lockdowns?Bike-Linked Head Injuries Plummet for U.S. Kids, But Not AdultsDialysis Patients Have Weaker Response to COVID Vaccine: StudyWith New Mask Guidance Comes the Challenge of Following ItWeight-Loss Surgery Might Also Help Prevent CataractsAHA News: What to Tell Your Young Teen About Their Shot at the COVID-19 VaccineWhat Works Best to Ease Recurrent Ear Infections in Kids?Mixing COVID Vaccines Might Raise Odds for Minor Reactions: StudyCOVID More Lethal for People Living With HIVNew Drug Shows Promise Against Tough-to-Manage AsthmaFully Vaccinated Can Shed Masks in Most Outdoor, Indoor Settings: CDCAHA News: 5 Things to Know About Blood Pressure Before It's a ProblemModerna Vaccine Can Trigger Red, Itchy 'COVID Arm,' But It's TemporaryCould a Vaccine Against Future Pandemics Be on the Way?Debunking Social Media Myth, Study Finds COVID Vaccine Won't Harm PlacentaU.S. Seniors Are Getting Fewer Abdominal SurgeriesMost Severe COVID Cases Involve Neuro Issues, and They're More Often FatalAny COVID-19 Infection Raises Odds for Lingering Symptoms, Study FindsNew Insights Into Treating Mild Head InjuriesAlcohol Is No Friend to Social DistancingGene-Targeted Drug Shows Promise Against a Form of Pancreatic CancerFDA Approves Emergency Use of Pfizer Vaccine for Those Aged 12 to 15Ibuprofen, Similar Painkillers Won't Raise Risks for COVID PatientsObesity Raises Odds for Many Common CancersAsthma Attacks Plummeted During PandemicWhy Sleep Raises Risk for Sudden Death in People With EpilepsyLockdown Loneliness Making Things Even Tougher for Cancer PatientsCOVID Vaccines May Still Leave Organ Transplant Recipients UnprotectedPfizer, Moderna or J&J? An Expert Answers Your QuestionsHow Summer Camps Can Shield Your Kids from Allergies, Asthma & COVIDCould Your Child Have a Heart Defect? Know the Warning SignsGene Tied to Balding May Also Raise COVID Risks for MenTime Spent in ICU Linked to Higher Odds for Suicide LaterState of Mind Matters for Survival After Heart AttackFailing Kidneys Could Bring Higher Dementia RiskAir Pollution Can Harm Kids' Hearts for a LifetimePoll Finds Many Parents Hesitant to Get Younger Kids VaccinatedObesity More Deadly for Men Than Women When COVID StrikesIsrael Study: Pfizer Vaccine Gives 95% Protection Against Illness, Hospitalization & DeathReal-World Studies Show Pfizer Vaccine Shields Against COVID Variants1 in 4 U.S. Teens Has Had a Concussion: StudyWhat's the Right Amount of Sleep for a Healthy Heart?U.S. COVID Outlook Shows Big Improvement by July'Prediabetes' Raises Odds for Heart Attack, StrokeA Vitamin Could Be Key to Women's Pain After Knee ReplacementBiden Sets New Goal of Vaccinating 70% of Americans by July 4Wildfires Are Changing the Seasonal Air Quality of the U.S. WestMany Americans Wrong About Sun's Skin Cancer Dangers: PollNot Just About Antibodies: Why mRNA COVID Vaccines May Shield From VariantsYou Got Your COVID Shot: What to Do With That Vaccine Card
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID Plus 'Bleeding' Stroke Doubles a Patient's Death Risk

HealthDay News
by Robert Preidt
Updated: Apr 15th 2021

new article illustration

THURSDAY, April 15, 2021 (HealthDay News) -- 'Bleeding' stroke patients with COVID-19 are more than twice as likely to die as those without COVID-19, new research shows.

For the study, a research team from the University of Utah analyzed data from 568 hospitals in the United States. They compared a control group of more than 23,300 patients without COVID-19 who suffered a bleeding (hemorrhagic) stroke to 771 COVID-19 patients who had hemorrhagic strokes.

"This is one of the first studies to document that, in patients with hemorrhagic stroke who have comorbid [occuring at the same time] COVID-19, there is a significantly elevated risk of in-hospital death," said senior study author Dr. Adam de Havenon, assistant professor of neurology.

"This finding warrants additional study and potentially more aggressive treatment of either condition," he said in a university news release.

The study patients were grouped by the type of bleeding stroke they suffered: intracerebral hemorrhage (ICH), caused by bleeding within the brain; or subarachnoid hemorrhage (SAH), caused by bleeding from a damaged artery on the brain's surface.

Compared to ICH patients in the control group, the 559 patients with both COVID-19 and ICH had a higher in-hospital death rate (46% versus 18%); longer hospital stays (21 days versus 10); and longer intensive care unit (ICU) stays (16 days versus six).

About half of the ICH patients in the control group had favorable outcomes, compared with about one-quarter of ICH patients with COVID-19, according to the report.

Compared to SAH patients in the control group, the 212 patients with COVID-19 and SAH had a higher percentage of in-hospital death (43% versus 15%); longer hospital stays (27 days versus 13), and more time in the ICU (22 days versus nine).

Thirty-one percent of SAH/COVID-19 patients had a favorable outcome, compared to 65% of the control group.

COVID-19 patients with both kinds of stroke were more likely to be intubated and have acute coronary syndrome, acute kidney failure, or pulmonary embolisms (blood clots in the arteries of the lungs) than those in the control group, the study found.

The report was published April 14 in the journal PLOS ONE.

The investigators also found that nearly half of bleeding stroke patients with COVID-19 did not have their strokes until after they were admitted to the hospital.

The reason is unclear, but the researchers said patients admitted with COVID-19 were more likely to receive anticoagulation drugs, which could increase the risk of hemorrhagic stroke. They plan to investigate this in future studies.

The study authors also found that while white people accounted for more than half of the hemorrhagic strokes in the control group, patients from other racial and ethnic backgrounds had the majority of strokes among those who also had COVID-19. The researchers plan more investigation of that finding.

More information

The American Stroke Association has more on bleeding strokes.

SOURCE: University of Utah Health, news release, April 14, 2021